» Articles » PMID: 36650731

Use of Portable Air Purifiers to Reduce Aerosols in Hospital Settings and Cut Down the Clinical Backlog

Abstract

SARS-CoV-2 has severely affected capacity in the National Health Service (NHS), and waiting lists are markedly increasing due to downtime of up to 50 min between patient consultations/procedures, to reduce the risk of infection. Ventilation accelerates this air cleaning, but retroactively installing built-in mechanical ventilation is often cost-prohibitive. We investigated the effect of using portable air cleaners (PAC), a low-energy and low-cost alternative, to reduce the concentration of aerosols in typical patient consultation/procedure environments. The experimental setup consisted of an aerosol generator, which mimicked the subject affected by SARS-CoV-19, and an aerosol detector, representing a subject who could potentially contract SARS-CoV-19. Experiments of aerosol dispersion and clearing were undertaken in a variety of rooms with two different types of PAC in various combinations and positions. Correct use of PAC can reduce the clearance half-life of aerosols by 82% compared to the same indoor-environment without any ventilation, and at a broadly equivalent rate to built-in mechanical ventilation. In addition, the highest level of aerosol concentration measured when using PAC remains at least 46% lower than that when no mitigation is used, even if the PAC's operation is impeded due to placement under a table. The use of PAC leads to significant reductions in the level of aerosol concentration, associated with transmission of droplet-based airborne diseases. This could enable NHS departments to reduce the downtime between consultations/procedures.

Citing Articles

Interventions used to reduce infectious aerosol concentrations in hospitals-a review.

Brady G, Bennin F, de Koning R, Vindrola-Padros C, Clark S, Tiwari M EClinicalMedicine. 2025; 79():102990.

PMID: 39802303 PMC: 11718292. DOI: 10.1016/j.eclinm.2024.102990.


Study on the Effectiveness of a Copper Electrostatic Filtration System "Aerok 1.0" for Air Disinfection.

Albertini R, Colucci M, Viani I, Capobianco E, Serpentino M, Coluccia A Int J Environ Res Public Health. 2024; 21(9).

PMID: 39338083 PMC: 11431324. DOI: 10.3390/ijerph21091200.


Use of portable air purifiers to reduce aerosols in hospital settings and cut down the clinical backlog: a critical analysis.

Malek R, Al-Shehab U, Lo D Epidemiol Infect. 2023; 151:e86.

PMID: 37204033 PMC: 10265730. DOI: 10.1017/S0950268823000535.

References
1.
De Oliveira P, Mesquita L, Gkantonas S, Giusti A, Mastorakos E . Evolution of spray and aerosol from respiratory releases: theoretical estimates for insight on viral transmission. Proc Math Phys Eng Sci. 2021; 477(2245):20200584. PMC: 7897643. DOI: 10.1098/rspa.2020.0584. View

2.
Barnewall R, Bischoff W . Removal of SARS-CoV-2 bioaerosols using ultraviolet air filtration. Infect Control Hosp Epidemiol. 2021; 42(8):1014-1015. PMC: 8007938. DOI: 10.1017/ice.2021.103. View

3.
Sargsyan N, Karunaratne D, Masani A, Howell L, Yousif M . ENT Telephone Clinics During the Coronavirus Pandemic: An Analysis of 400 Telephone Consultations at a District General Hospital. Ear Nose Throat J. 2021; 102(11):733-738. DOI: 10.1177/01455613211028091. View

4.
Arnold D, Gregson F, Sheikh S, Hamilton F, Welch H, Dipper A . Standard pleural interventions are not high-risk aerosol generating procedures. Eur Respir J. 2021; 58(4). PMC: 8555490. DOI: 10.1183/13993003.01064-2021. View

5.
Allen J, Ibrahim A . Indoor Air Changes and Potential Implications for SARS-CoV-2 Transmission. JAMA. 2021; 325(20):2112-2113. DOI: 10.1001/jama.2021.5053. View